Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Newsroom

Corporate News Release

Bioniche Serves Community Needs Through New Pet Loss Program

14/06/04

-- an innovation from Bioniche Animal Health Canada –

BELLEVILLE ON, June 14, 2004 – Bioniche Life Sciences Inc. (TSX: BNC), a fully-integrated, human and animal health biopharmaceutical company, today announced the launch of its innovative new Pet Loss Program to assist pet owners and veterinary clinic staff to better deal with the death of a pet. This new Program, developed by Bioniche Animal Health Canada, is being introduced at the 1st International Conference on Communications in Veterinary Medicine, being held in Niagara-on-the-Lake, Ontario this week.

“As members of the animal health industry, we encourage the human-animal bond,” said Rick Culbert, President of Bioniche Animal Health Canada. “We have an obligation to ensure that, when pets leave our lives, it is done with care and that they are suitably remembered.”

Dr. Cindy Adams, faculty member at the Ontario Veterinary College, University of Guelph, participated in this initiative with Bioniche Animal Health. “We are finally catching up with the needs and wants of clients as it relates to memorializing and commemorating the life of their pet,” she added.

The Bioniche Pet Loss Program includes a Clinic Guide, an educational resource for veterinarians and their staff, and a Pet Loss Sympathy Package for the client. The Pet Loss Sympathy Package includes an educational booklet, “Coping with Pet Loss”, a blanket (for use during the procedure and to wrap the deceased pet), a pewter memento, a picture frame, and space to store other linking objects related to the pet.

“Although it does not fall into one of the primary technology categories within our Animal Health Division,” said Graeme McRae, President & CEO of Bioniche Life Sciences Inc., “the Pet Loss Program and its components fit very well with our corporate values. We are an ethical company that believes in being socially responsible in the directions we take. We are innovative in the development of new products, while being compassionate about improving the quality of life and, in this case, the quality of the end of life for pets and those who love them.”

To help in the ongoing efforts to communicate compassion at the time of pet loss, Bioniche Animal Health Canada is pleased to provide proceeds from the sale of the Pet Loss Sympathy Package to qualifying associations or projects. More information is available by contacting petloss@Bioniche.com.

About Bioniche Animal Health

The Animal Health Division of Bioniche Life Sciences Inc. has marketing subsidiaries in Australia, Canada, Europe, and the United States. It is responsible for research, development, manufacturing, and marketing of veterinary biologics, pharmaceuticals, and nutritionals. This Division has a global portfolio of more than 60 products based on five platform technologies. The products fall into the categories of: reproduction and embryo transfer; immunostimulant; and vaccine.

###


Back

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy